Cordova Ashley 4
4 · NovoCure Ltd · Filed Mar 3, 2026
Insider Transaction Report
Form 4Exit
NovoCure LtdNVCR
Cordova Ashley
Former Chief Executive Officer
Transactions
- Tax Payment
Ordinary Shares
[F1]2026-02-27$13.75/sh−11,541$158,689→ 426,028 total - Award
Ordinary Shares
[F2]2026-02-28+23,818→ 449,846 total - Tax Payment
Ordinary Shares
[F1]2026-03-02$13.67/sh−2,410$32,945→ 447,436 total - Tax Payment
Ordinary Shares
[F1]2026-03-02$13.67/sh−7,228$98,807→ 440,208 total
Footnotes (2)
- [F1]Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).
- [F2]Represents vesting of performance-based restricted stock units.
Signature
Steven Robbins, as attorney in fact for Cordova, Ashley|2026-03-03